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A PAX1 enhancer locus is associated with
susceptibility to idiopathic scoliosis in females
Swarkar Sharma1,w, Douglas Londono2, Walter L. Eckalbar3, Xiaochong Gao1, Dongping Zhang1, Kristen Mauldin1,
Ikuyo Kou4, Atsushi Takahashi5, Morio Matsumoto6, Nobuhiro Kamiya1,w, Karl K. Murphy3, Reuel Cornelia1,
TSRHC Scoliosis Clinical Group*, Japan Scoliosis Clinical Research Group*, John A. Herring7,8, Dennis Burns9,
Nadav Ahituv3, Shiro Ikegawa4, Derek Gordon2 & Carol A. Wise1,8,10,11
Idiopathic scoliosis (IS) is a common paediatric musculoskeletal disease that displays
a strong female bias. By performing a genome-wide association study (GWAS) of
3,102 individuals, we identify significant associations with 20p11.22 SNPs for females
(P¼ 6.89 109) but not males (P¼0.71). This association with IS is also found in
independent female cohorts from the United States of America and Japan (overall
P¼ 2.15 10 10, OR¼ 1.30 (rs6137473)). Unexpectedly, the 20p11.22 IS risk alleles were
previously associated with protection from early-onset alopecia, another sexually dimorphic
condition. The 174-kb associated locus is distal to PAX1, which encodes paired box 1, a
transcription factor involved in spine development. We identify a sequence in the associated
locus with enhancer activity in zebrafish somitic muscle and spinal cord, an activity that is
abolished by IS-associated SNPs. We thus identify a sexually dimorphic IS susceptibility locus,
and propose the first functionally defined candidate mutations in an enhancer that may
regulate expression in specific spinal cells.
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S
coliosis is defined as a curvature of the thoracolumbar spine
greater than 10 in the coronal plane. Scoliosis is frequently
secondary to other underlying diseases or seen as part of the
phenotypic spectrum of heritable syndromes, in particular,
disorders of neuromuscular or connective tissue development.
In other patients, so-called ‘congenital’ scoliosis arises from frank
malformations of the vertebrae that are most often isolated
segmentation defects. However, for more than 80% of patients,
the origins of scoliosis are unknown, occurring in individuals who
are otherwise healthy and bear no obvious structural deficiencies
in the vertebral column and associated soft tissues1.
This ‘idiopathic’ scoliosis (IS) is the most common paediatric
musculoskeletal disorder, affecting B3% of children worldwide2.
The onset of IS typically coincides with the adolescent growth
spurt. Affected individuals are at risk for increasing deformity
until growth ceases, although patients with large curves (450)
may continue to worsen more slowly throughout adulthood1,3.
Severe IS warrants surgical correction to prevent later
disfigurement and other co-morbidities including back pain and
pulmonary dysfunction1,2. Progression of the deformity can be
rapid, prompting many states in the United States to require
school screenings for early detection4.
Multiple biologic phenotypes are suspected in IS but have
proven difficult to define, particularly as the involved structures,
that is, the spine and associated soft tissues, appear superficially
normal5. Functional and clinical assessments have associated
IS with both neuropathologic/neuromuscular as well as
connective tissue abnormalities5,6. These studies hint at
multiple subphenotypes in human IS but have not defined
causality. Aetiologic understanding of IS has also suffered from a
lack of tractable, genetically defined animal models that clearly
re-capitulate the phenotype. However, recent descriptions of
IS-like phenotypes in both naturally occurring and genetically
engineered teleosts hold out promise in this regard7. In particular,
forward genetic and genome editing approaches in zebrafish
(Danio rerio) have recently produced strains with an IS-like
phenotype, suggesting that this system may be a powerful tool for
modeling IS and defining its disease mechanisms8,9.
IS is a sexually dimorphic disease10. Girls and boys exhibit a
striking difference in the prevalence of progressive IS, with girls
having approximately tenfold greater risk of progressive curves
that require operative treatment11. This dichotomy in female/
male disease expression, and its correlation with the adolescent
growth spurt have prompted investigations of hormonal
influences in the development and progression of female IS6.
Sexual dimorphism in IS has also been attributed to differences in
genetic loading between males and females, with the least affected
sex (males) requiring a stronger genetic load to acquire disease, a
so-called Carter effect. One study of a cohort of multiplex families
has provided epidemiological evidence for this genetic model12.
Genetic influences in IS were first suggested almost a century
ago5. Segregation studies support a complex inheritance model in
which multiple genetic factors contribute greater than 80% of the
overall disease risk in IS13,14. Although most cases are sporadic,
about 25% of IS patients report family history of IS, and more
rare families with apparent Mendelian, or single-gene inheritance
are described15. Early gene discovery efforts centred on applying
traditional linkage mapping methods to search for causal genes in
such extended pedigrees. These studies defined five IS candidate
loci as noted in the Online Mendelian Inheritance in Man
(OMIM): OS1 (OMIM 181800, chr19p13.3), OS2 (OMIM
607354, chr 17p11), OS3 (OMIM 608765, chr 8q12.1-12.2),
OS4 (OMIM 612238, chr 9q31-q34) and OS5 (OMIM 612239,
chr 17q25-qter). All but OS3 were defined in single extended
pedigrees16,17–19. Common single-nucleotide polymorphisms
(SNPs) for one candidate gene within OS3, CHD7, were
significantly associated with IS in a cohort of 52 families19.
Otherwise, the causal genes and mutations encoded within
familial IS disease loci have not been forthcoming, most likely due
to issues of genetic heterogeneity in IS that can confound
traditional gene discovery approaches20.
As with other complex genetic disorders, the overall genetic
architecture of IS is expected to reflect genetic factors with
varying frequencies and effect sizes that will be discoverable by
sequence- and haplotype-based methods21. Population-based
genome-wide association studies (GWAS), a method only
recently applied to IS, have proven powerful and efficient for
mapping common susceptibility loci for hundreds of complex
human traits22. Three published GWAS of IS have begun to
define IS susceptibility loci23–25. A locus on chromosome 10q24.1
is the most studied and was initially identified by GWAS of 1,033
East Asian (Japanese) cases and 1,473 matched controls24.
A recent combined analysis from multiple ethnic groups (that
is, mostly East Asian and non-Hispanic white, NHW) provided
further evidence for the locus, which is in the proximity of the
LBX1 gene (combined P¼ 1.22 10 43 for rs11190870)26. LBX1
encodes the ladybird homeobox 1 protein that is important for
early muscle patterning as well as specification of dorsal horn
neurons in developing spinal cord27–29. Causal mutations
underlying this association and their potential effects on LBX1
and/or other genes are not yet defined. A separate expanded
analysis of the original East Asian GWAS yielded significant
association with SNPs at a second locus, within the GPR126 gene in
chromosome 6, a result that was replicated in both East Asian and
NHW cohorts25. GPR126 encodes G-protein-coupled receptor 126
that is critical in early neurologic development and Schwann cell
myelination30. It is interesting that SNPs in GPR126 also have been
associated with sitting height in humans31. In total, reported
associations are estimated to explain less than 5% of the overall
genetic contribution to disease risk. How these loci function in IS
pathogenesis is as yet undefined25,26.
To discover new genetic risk factors for IS, we performed a
two-stage GWAS in 3,102 individuals. Our results define a new
susceptibility locus encoding associated SNPs that, surprisingly,
are also associated with androgenic alopecia (AGA), or male
pattern baldness. We find that the locus is specifically associated
with female IS, suggesting that it contributes to the sexually
dimorphic expression of the disease. By functional fine-mapping
assays in zebrafish, we further define a sequence in the associated
locus with enhancer activity that is abolished by IS-associated
SNPs. Altogether, our results identify the first functionally
characterized candidate mutations for IS susceptibility and
expand our understanding of the role of non-coding regulatory
elements in the disease. Our findings also suggest hypotheses to
explain disease pathogenesis and provide the first insights into its
puzzling sexual dimorphism.
Results
Association with common variants near the PAX1 gene.
Research subjects included in the two-stage GWAS were ascer-
tained in Paediatric Orthopedic Clinics at the Texas Scottish Rite
Hospital for Children (TSRHC). Affected individuals met stan-
dard criteria for a diagnosis of IS and had spinal deformity
measuring at least 15 by the Cobb angle method (Fig. 1a,b). The
GWAS I-715 included 715 trios from 702 trio families (parents
and affected offspring, N¼ 1,876 total) a portion of which was
previously described23. The GWAS II case–control study included
482 independent IS-affected cases and 744 controls of self-
reported NHW ethnicity that were independent of GWASI-715.
Further ascertainment, genotyping, quality control and statistical
methods are described in the Methods section. In the first stage,
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we genotyped GWAS II cases and controls using the Illumina
HumanOmniExpress-12 v1.0 beadchip containing 730,498
markers. We used PLINK v1.07 (ref. 32 to perform quality
assurance (QA) and test the data for association using the
Cochran Armitage trend test (CATT). This analysis replicated the
previously reported associations near LBX1 and GPR126 (refs 24–
26). However, we found strongest results with SNPs rs6137473
(CATT, P¼ 5.58 10 7, odds ratio (OR)¼ 1.53, 95% confidence
interval (CI)¼ 1.29–1.80 for risk allele G) and rs169311 (CATT,
P¼ 1.25 10 6, OR¼ 1.51, 95% CI¼ 1.28–1.78 for risk allele A)
in a region of chromosome 20p11.22 between the PAX1 and
FOXA2 genes (Fig. 2). SNPs in the 20p11.22 inter-genic region
remained the most significantly associated with IS after imputing
additional genotypes for all of chromosome 20 (Supplementary
Fig. 1). For the second stage, we expanded a prior GWAS23 from
419 to 715 parent-offspring trios (‘GWAS I-715’, 1,876
individuals). The ethnic composition of this cohort is given in
Supplementary Fig. 2. All trios were analysed together using
TDT-HET, a transmission disequilibrium test that allows for locus
heterogeneity, and is robust to population stratification33. Results
of the two stages in the 20p11.22 region (chr20: 21,815,192–
21,988,830) were combined using a set association method as
implemented in Sumstat34 and TDT-HET33. The set association
method performs multi-locus association by estimating sum
statistics for an increasing number of SNPs to evaluate their joint
effect on disease. Sumstat and TDT-HET were used because to
generate a single P-value calculated for the entire region in each
study, thereby minimizing the number of tests performed.
Previous work has shown that these methods have sufficient
power to identify SNPs acting in additive and/or multiplicative
manners to increase disease risk35. The P-value obtained by
applying either Sumstat or TDT-HET represents the global
significance of the candidate chromosomal region. Combining the
two stages in this way yielded increased evidence for association
with IS in the 20p11.22 region, with a combined Fisher’s
P¼ 1.33 10 8 (Fig. 2 and Table 1) and ORs depicted in
Supplementary Fig. 3.
Comparing our results to the National Human Genome
Research Institute (NHGRI) GWAS catalogue22, we found that
the chromosome 20 IS locus was previously associated with early-
onset male pattern baldness (AGA). Similar to IS, AGA displays
sexual dimorphism, that is, it is biologically unequal in males and
females. However, unlike IS, disease progression in AGA (extent
of hair loss) is generally more severe in males than in females36.
We identified chromosome 20p11.22 SNPs that were previously
associated with AGA and that were genotyped in our
GWAS37–39. In this comparison, SNPs that were associated
with IS and AGA displayed the opposite direction of effect for
the two disorders (Supplementary Table 1). This observation
suggested that sequences in the region conferring susceptibility to
IS have a protective effect in AGA. To test whether the association
we observed was sex-specific, we re-evaluated association with
SNPs in the 20p11.22 locus after stratification by sex, that is,
separating males and females. This analysis yielded evidence for
association with IS in females but not males, with a combined
Fisher’s P¼ 6.88 10 9 in the former data set (Table 1 and
Supplementary Tables 2 and 3).
To confirm the chromosome 20p11.22 association with IS, we
genotyped SNP rs6137473, as it was highly correlated with other
top-associated SNPs in the region, in an independent cohort of
216 IS patients ascertained from various paediatric orthopaedic
clinics throughout the United States of America and 336
population-matched controls. This variant was significantly
associated with IS in females (P¼ 2.4 10 4; OR¼ 1.67, 95%
CI¼ 1.27–2.21) but not males (P¼ 0.726; OR¼ 0.90, 95%
CI¼ 0.49–1.64; Table 2 and Supplementary Table 4). Data
provided from a GWAS of female Japanese subjects24 also
replicated association with the 20p11.22 region (rs6137473
P¼ 3.7 10 3; summary P¼ 3 10 3; Table 2 and
Supplementary Table 5). Results from all four studies were
combined and confirmed the association of rs6137473 with IS for
females (P¼ 2.15 10 10, OR¼ 1.30, 95% CI¼ 1.19–1.41;
Table 2).
Putative enhancers in the chr20p11.22 susceptibility locus.
PAX1 is a key regulator of sclerotome formation and vertebral
development40. Naturally occurring missense and deletion
mutations in Pax1 are well-described in the ‘undulated’ and
Figure 1 | Idiopathic scoliosis in an adolescent female. (a) Lateral radiograph reveals prototypical right thoracic spinal curvature. Shoulder imbalance is
evident in clinical photograph. (b) Prominent rib hump is evident on forward bending.
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‘scoli’ mouse strains, so-called because of their distinct tail
deformities and varying spinal malformations including
scoliosis40–42. The orthologous 20p11.22 IS-associated locus
overlaps a regulator of murine Pax1 expression in the
developing spine (sclerotome) as identified by murine enhancer
trap and reporter assays43. In the latter study, deletions of the
region including Pax1 caused a corresponding reduction in gene
expression in the sclerotome at embryonic day 11.5 (E11.5).
Moreover, an B1.5-kb sequence ‘Xe1’ encoded in the deleted
region recapitulated a Pax1 expression pattern43. We
hypothesized that variants in the IS-associated region may
affect PAX1 regulatory elements. Using comparative genomics
and ENCODE data for biologically relevant cell lines, human
skeletal muscle myoblast and human embryonic stem cells
(H1-hESC)44, we analysed the associated region (chr20:21,815,
192–21,988,830; hg19) for sequences representing putative
regulatory elements. We identified ten candidate regions (PAX1
Enhancer Candidates ‘PEC1’, ‘PEC2’ and so on), including
sequences orthologous to the previously described ‘Xe1’ enhancer
(Fig. 2 and Supplementary Table 6). To test the ability of each
candidate to function as an enhancer, that is, to drive gene
expression, we cloned each PEC including Xe1 into the E1b-GFP-
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Figure 2 | Chromosome 20p11.22 regional association plot.  Log 10 (P-value) of association with IS is plotted versus chromosomal position for each
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Tol2 enhancer assay vector and successfully tested seven of them
in zebrafish as previously described45. As expected, Xe1 showed
enhancer activity in the developing spine, specifically
corresponding to somitic muscle (Fig. 3a). One other candidate,
PEC7, also displayed functional enhancer activity. Similar to Xe1,
PEC7-driven expression of the green fluorescent protein (GFP)
reporter was largely restricted to somitic muscle, with weaker
expression in spinal cord and heart (Fig. 3b). Thus, Xe1 and PEC7
clearly harboured enhancer activity, possibly in developing spinal
muscle, although more detailed studies are needed to precisely
define the temporo-spatial effects of these enhancers on gene
expression in humans. It is worth noting that PEC7 enhancer
expression did not completely overlap the characterized pax1b
expression in zebrafish at 48 h post-fertilization (h.p.f.)46. This
could be due to the testing of human sequences in zebrafish.
However, previous work has shown that human enhancer
sequences can function as active enhancers in zebrafish, even
without homologous sequences in zebrafish47–50. In addition, the
expression pattern of pax1a has yet to be determined in zebrafish,
and we cannot exclude the possibility that PEC7 controls the
expression of other genes.
Disruption of enhancer activity by IS-associated SNPs. To
search for disease alleles potentially underlying the association
with IS, the Xe1 and PEC7 regions were re-sequenced in 48 cases
that were enriched for chromosome 20 risk alleles as identified in
the original GWAS. Although no variants were detected in Xe1 in
these individuals, a haplotype of five variants including top-
Table 1 | GWAS summary statistics.
Stage I Stage II Combined
N (cases/controls) P-value OR Trios (subjects) P-value OR P-value OR
Total 447/737 2 10 5 1.44 715 (1,876) 3 10 5* 1.23 1.33 10 8 1.31
Females 371/533 1 10 5 1.54 600 (1583) 3 10 5* 1.21 6.88 109 1.35
Males 76/204 0.631 1.08 115 (293) 0.543 1.25 0.71 1.15
GWAS, genome-wide association study; OR, average odds ratio.
Summary statistics obtained using Sumstat34 and TDT-HET33 were applied to SNPs in the chromosome 20 region spanning genomic positions 21,815,192 to 21,988,830 in both data sets. Combined
P-values were calculated Fisher’s Combined P-value method65.
*Actual permutation P-value was 0. The value in the table is the upper bound of the 95% confidence interval determined by the BINOM programme.
Table 2 | rs6137473 association results in all data sets.
Study Risk allele Females Males Combined
P OR (95% CI) P OR (95% CI) P
Stage I G 2.36 10 7 1.64 (1.36–1.98) 0.67 1.09 (0.75–1.58) 5.58 10 7
Stage II G 0.19 1.16 (0.93–1.45) 0.45 1.21 (0.74–1.97) 0.13
TSRHC III G 2.40 104 1.67 (1.27–2.21) 0.73 0.90 (0.49–1.64) 1.50 10 3
Japan G 3.70 10 3 1.18 (1.06–1.33) NA NA NA
Combined 2.15 10 10 1.30 (1.19–1.41) 0.81 1.08 (0.82–1.41) 3.12 108
CI, confidence interval; NA, data not available; OR, odds ratio; TSRHC, Texas Scottish Rite Hospital for Children.
Results of allelic association tests performed using Cochran Armitage trend test are shown for the case–control studies (Stage I, TSRHC III and Japan). TDT-HET P-values are shown for the family-based
study (Stage II).
Figure 3 | Functional enhancer assays in zebrafish. (a) Representative zebrafish (of at least 100 tested for each construct) injected with Xe1-E1b-GFP-Tol2
enhancer construct showing expression predominantly in the somitic muscle. (b) Representative zebrafish injected with PE7-E1b-GFP-Tol2 enhancer
construct showing expression predominantly in the somitic muscle. (c) Representative zebrafish injected with PEC7risk-E1b-GFP-Tol2 enhancer construct
leads to loss of expression throughout. Corresponding pictures at higher magnification are shown below.
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associated SNP rs169311 was identified in PEC7 (Supplementary
Table 7). Using Haploreg51, we noted that top SNP rs169311 is
predicted to alter binding sites for component of myogenesis
protein 1 and vitamin D receptor, and three other PEC7 SNPs are
also predicted to alter transcription factor-binding sites
(Supplementary Table 7). We compared the ability of the risk
haplotype to drive zebrafish reporter gene expression to that of
the wild-type sequence. Four independent replicate experiments
confirmed that the associated haplotype completely abolished
enhancer activity as detected by this assay, suggesting that the IS
susceptibility haplotype confers a loss of function for PEC7
enhancer activity (Fig. 3c and Supplementary Data set 1).
PAX1 expression in spinal myofibers post-somitogenesis.
In the developing mouse embryo, Pax1 expression is well-
described in somitogenesis, beginning at E8.5 in the stage III
somite and continuing to E12.5, becoming restricted to cells
surrounding the vertebrae, intervertebral disc anlagen and pre-
cursors to the connective tissue around spinal nerve and dorsal
root ganglia40,41. As vertebral structures and segmentation appear
normal in IS, we hypothesized a role for PAX1 in spinal
development post-somitogenesis. Accordingly, we examined Pax1
protein in mouse spinal tissues at seven developmental time
points from E13.5 to postnatal day 84 (P84). As shown in
Fig. 4a–c, Pax1 immunohistochemical staining was essentially
negative post-somitogenesis at E13.5. However, at E16.5, we
observed a striking pattern in developing myofibers, with more
modest staining in other cells types. Weaker but persistent
staining was evident in myofibers up to stage P84. Pax1 was
essentially absent in other spinal cell types (Supplementary
Fig. 4). These data demonstrate a potential role for Pax1 in spine
development post-somitogenesis, possibly in paraspinous muscles.
Discussion
We present evidence of a new IS susceptibility locus in an
B100-kb region of chromosome 20p11.22 downstream of PAX1.
Using a functional fine-mapping approach, we potentially narrow
the locus to an B1.5-kb domain with enhancer activity that is
disrupted by disease-associated variants. The PAX1-encoding
region was originally associated with spinal development through
studies of the naturally occurring undulated mouse strains. The
original undulated (un) strain, first described in 1947, carries a
missense mutation in Pax1 (ref. 41). Un/un mice display a curved
spine with malformations of individual vertebrae including the
vertebral bodies and intervertebral discs. Three additional strains,
scoliosis (sco) or undulated intermediate (un-i), undulated-
extensive (unex), undulated short-tail (uns), harbour partial or
complete deletions of PAX1, with the latter including all of the
gene and displaying the most severe phenotype41,42. In early
mouse development, Pax1 displays expression restricted to
specific structures including the sclerotome that will give rise to
the axial spine (vertebrae, ribs, connective tissues and skin).
Neural tube/spinal cordMuscleCartilageBone
E13.5
E16.5
E18
P1
P14
Figure 4 | Pax1 immunohistochemistry in developing mouse spinal tissues. Spines and surrounding soft tissue harvested at E13.5, E16.5, E18, P1 and P14
are shown in each row. Representative images for bone, cartilage, muscle and nerve are shown in the columns, with the exception of bone at E13.5,
as it was not well-formed at that time point. Muscle was also not well-formed at E13.5 and had a soft tissue appearance. In contrast, strong nuclear staining
(brown) was clearly seen in osteoblasts, myoblasts and ependymal cells at E16.5, with weaker chondrocyte staining. More modest staining was evident at
E18 and P1 in all tissues. By P14, Pax1 staining persisted in muscle but was essentially absent from bone and cartilage (note positive staining in muscle
surrounding cartilage and adjacent to bone). Very weak staining was observed in a subset of spinal cord cells, possibly glia, at P14. Each experimental time
point was repeated at least once. Scale bar, 20mM.
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Genomic studies have delineated intervals downstream of Pax1
harbouring cis-regulatory activity consistent with this pattern43.
In particular, transposon-based deletion mapping and reporter
gene assays defined theB148-kb region 30 of Pax1 as necessary to
drive somitic gene expression (that is, in the dorsal sclerotome)
during early mouse development. Furthermore, the mouse Xe1
enhancer encoded in this region was shown to be sufficient to
drive a similar expression pattern43. Our data using zebrafish
transgene assays confirmed the enhancer activity of the human
Xe1 orthologue and revealed another element in the region,
PEC7, with potential somitic enhancer activity that was disrupted
by IS-associated sequence variants. This observation strongly
suggests that PEC7 itself functions in IS susceptibility, a
hypothesis that may be tested in model systems by targeted
mutagenesis.
The spinal anomalies observed in Pax1 mouse mutants
recapitulates a congenital scoliosis phenotype, although muta-
tions in human PAX1 are not clearly correlated with this
condition52. By contrast, the structure of the axial spine in IS
appears normal. Consequently, we reasoned that either the
association we observed reflects functional effects on a gene other
than PAX1, or an effect on the participation of PAX1 in a post-
somitogenesis developmental role. In support of the latter
hypothesis, we found that Pax1 is strongly expressed in
developing myofibers of the mouse spine at day E16.5, well
after the somites are formed, and that expression persisted at least
to early adulthood, albeit at reduced levels. It is intriguing to
consider that PAX1 may participate in multiple roles in spinal
development that are dictated by the spatio-temporal control of
its expression. Such a scenario predicts that deleterious mutations
that occur in PAX1-coding sequences, versus those that occur in
its regulatory elements, will give rise to distinct but potentially
overlapping phenotypes. This phenomenon is well-described for
other early developmental genes. For example, coding mutations
in the sonic Hedgehog gene produce the severe multi-system
disorder holoprosencephaly, whereas mutations in the sonic
Hedgehog cis-regulator ZRS cause limb-specific pre-axial
polydactyly53,54. Whether congenital scoliosis and IS may be
aetiologically connected in humans is unclear but has been
suggested from familial aggregation studies55–57. An aetiologic
relationship between the two diagnoses is also supported by the
recent discovery that ptk7 mutant zebrafish model both IS- and
CS-like phenotypes in zygotic and maternal-zygotic genetic
backgrounds, respectively8. The latter study also illustrates the
distinct morphologies that may arise from the differential
expression of key developmental genes.
Our investigation of the chromosome 20p11 locus provides the
first genetic evidence to explain the puzzling sexual dimorphism
that is a hallmark of IS. Besides susceptibility to progression, the
pattern, onset and flexibility of deformity also differ between boys
and girls10. Various hypotheses have been proposed to explain
male/female differences in IS, including the existence of X-linked
genetic risk factors and effects on circulating hormones. Neither
mechanism has been clearly supported, although investigations
have been limited6,58. Our identification of a female-specific IS
susceptibility locus suggests an underlying mechanism that is
sensitive to the female milieu at the time of adolescence. Although
we did not find evidence for oestrogen receptor-binding sites
within the PEC7 enhancer locus itself, it is interesting to postulate
that this locus increases risk of IS via downstream hormonal
interactions. We note in this regard that the next-nearest gene,
FOXA2, is implicated in sexually dimorphic gene expression via
cooperation with androgen and oestrogen receptor59. It is
possible that PEC7 regulates FOXA2. However, we did not
detect Foxa2 expression in embryonic or postnatal mouse spine
(data not shown) and consider it an unlikely candidate for IS
susceptibility. PAX1 is also expressed in the adult scalp37.
Whether variants in PEC7 affect this expression and drive
association with early-onset male pattern baldness requires
further study, but the overlapping genetic association suggests a
possible correlation between the two sexually dimorphic
conditions.
We provide evidence that PAX1 is expressed in paraspinal
muscles, and to a lesser extent in spinal cord, at time points well
after the initial patterning of the axial skeleton has been
completed. This suggests a later developmental role for PAX1,
possibly in the growth or maintenance of these tissues. It is
interesting that other IS risk loci identified by GWAS occur in
non-coding regions near or within genes involved in muscle and
nerve biogenesis. In this regard, we expect that the functional
fine-mapping method applied in the present study should prove
fruitful for identifying the alleles and functional elements driving
association at other IS risk loci. Our results also imply that
additional sex-specific genetic loci may await discovery, and draw
attention to the need to consider males and females in separate
liability classes.
Methods
Study subjects. All research subjects included in GWAS I-715, GWAS II and
TSRHC III provided written informed consent to participate in the study as
approved by the Institutional Review Board of the University of Texas South-
western Medical Center. For GWAS I and II, patients or former patients were
sequentially ascertained in Orthopedic Clinics at TSRHC and enrolled into an
idiopathic scoliosis (IS) registry. Parents and other affected family members were
also ascertained when possible. For TSRHC III, 216 NHW cases were included
from cases ascertained in TSRHC clinics or through collaborating orthopaedic
surgeons in the United States of America at Shriners Hospital for Children,
Lexington, KY (T. Milbrandt, V. Talwalkar, H.J. Iwinski, R. Muchow); Hasbro
Childrens’ Hospital, Providence, RI (C.P. Eberson); University of Massachusetts
Memorial Medical Center, Worcester, MA (A. Lapinsky); Childrens Hospital of
Wisconsin, Milwaukee, WI (J.C. Tassone, X.C. Liu) and Akron Children’s Hospital,
Akron, OH (W. Schrader); OrthoArizona Phoenix, AZ (R. Shindell); Indiana
University-Purdue University Indianapolis, Indianapolis, IN, (R. Loder); University
of Oklahoma Health Sciences Center, Oklahoma City, OK (J. Davey). All affected
subjects in these cohorts met criteria for a positive diagnosis of IS: lateral deviation
from the midline greater than 15 as measured by the Cobb angle method from
standing spinal radiographs, axial rotation towards the side of the deviation and
exclusion of relevant co-existing diagnoses. Blood samples were obtained by
venipuncture. In some cases, saliva samples were self-collected using the Oragene
DNA kit (DNA Genotek, Inc.). Control individuals were ascertained from within
the local Texas population or non-orthopaedic clinics at TSRHC. A diagnosis of
scoliosis, or family history of scoliosis, was excluded by questionnaire. To reduce
the possibility of biases due to population stratification in the TSRHC III cohort,
we previously genotyped 384 ancestry informative markers and performed multi-
dimensional scaling analysis of identity-by-state distances to identify outliers23.
The Japanese cohort consisted of 1,050 Japanese females with adolescent IS
recruited from eight collaborating hospitals (Japan Scoliosis Clinical Research
Group: JSCRG) between February 2009 and January 2011. All subjects with
adolescent IS underwent clinical and radiologic examinations for IS as previously
described24. Subjects with definitive family history of Mendelian inheritance were
excluded from the study. The control subjects consisted of 1,474 Japanese females,
including healthy volunteers from the Midosuji Rotary Club, Osaka, Japan, and
individuals who were registered in the BioBank Japan Project but were genotyped
in GWAS of other diseases, as previously described60. Informed consent was
obtained from all Japanese subjects and from parents of minor subjects according
to a protocol approved by the ethics committees of the University of Texas
Southwestern Medical Center, University of Kentucky, University of Massachusetts
Medical School, Children’s Hospital of Wisconsin, Akron Children’s Hospital,
Indiana University-Purdue University, Oklahoma University Health Sciences
Center and RIKEN.
GWAS genotyping, quality control, imputation and association testing. The
GWAS II data set was derived from 1,201 individuals (457 cases and 744 controls).
We chose the sample sizes to have 80% power to detect genetic association with
population data (cases and controls) at the 5E-08 significance level (that is, 0.05
genome-wide significance) using the following parameters: genetic model-based
design, disease prevalence of 0.03, heterozygote relative risk of 1.5, homozygote
relative risk of 2.25, disease allele frequency of 0.50, linear trend test statistic with
additive weights (0, 1, 2 for the three possible genotypes at a SNP). Using these
specifications, we compute a minimum sample size of 932 cases and 932 controls.
The combined Stage I and Stage II cohorts therefore exceeded the sample sizes
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required for our specified power. DNA samples from cases and controls were
distributed non-sequentially into plates and genotyped using the Illumina
HumanOmniExpress-12 v1.0 beadchip (Illumina, Inc.) containing 730,498 mar-
kers. Twenty-nine technical replicates were included and were 100% concordant.
We used PLINK v1.07 (ref. 32) to perform QA on these data. A total of 17
individuals were removed from the analyses. Fifteen had genotyping call rates
o95%. Two individuals had ambiguous gender information according to the
X-chromosome inbreeding coefficient61. SNP markers were evaluated for the
presence of heterozygous haploid (HH) genotypes and missingness. All markers on
chromosome Y with HH genotypes were removed. Markers on chromosome X
with HH genotypes were kept. Markers with more than 5% of missing data were
removed. A total of 2,828 markers (0.39%) failed QA. After all QA filters were
applied, a total of 1,184 individuals (447 cases and 737 controls) and 727,670
markers were included in the analyses (GWAS II). In addition, we checked for
population stratification confounder effects by applying the genomic control (GC)
method62. We obtained a correction factor (l) of 1.0992, potentially indicating a
slight inflation of the GWAS results due to population stratification. To study the
region in more detail, we used microarray genotypes to impute 1000 Genomes
(http://www.1000genomes.org) chromosome 20 variants with MACH63 (http://
www.sph.umich.edu/csg/abecasis/MACH/tour/imputation.html). Genotypes were
tested for association using CATT as implemented in the PLINK software32.
Genotyping and quality control for GWAS I-715 were as previously described23,24.
Nine individual samples were removed with genotyping call rates o95%. Of
345,111 SNPs, 1,514 (0.44%) had call rates less than 95% and were removed,
leaving 343,597 (99.56%) of SNPs. SNP markers corresponding to X and Y
chromosomes were also removed from the analysis. The Japanese GWAS was
analysed as described previously24,25.
Meta-analysis of Stages I and II, TSRHC III and Japan sets assumed a fixed
effect model and was carried out using the inverse variance weighting method.
Where applicable, meta-analyses of case–control and trio designs were performed
as described in Kazeem and Farral64.
Set association method. We applied the set association method, as implemented
in the Sumstat34 and TDT-HET33 software, to the region on chromosome 20
spanning 21,815,192–21,988,830 corresponding to a linkage disequilibrium (LD)
block harbouring top-associated SNPs from the second stage GWAS. We used this
method to obtain a single global P-value for the chromosomal region in each data
set (Stage I, Stage II and Japan). Our approach is similar to the analysis of variance
approach for testing equality of means across multiple categories. In this analogy,
we consider SNPs are categories. We applied TDT-HET to pedigree data from
Stage II and Sumstat to case–control data from Stage I and the Japan data set. We
obtained three P-values this way, each corresponding to a single data set (Stage I,
Stage II and Japan). Because each data set was independent, we used Fisher’s
Combined P-value method65 to compute a single P-value for the chromosomal
region.
Association analyses were performed using 100,000 permutations. None of the
markers in the selected regions failed either the Hardy–Weinberg proportions test
in the unaffected sample or presented significant differences in genotype calling
between cases and controls at the 0.1% level. In Supplementary Table 3, the actual
permutation P-value for the chromosome 20 region in GWAS I-702 (Stage II) was
0. We used the value P¼ 3 10 5 since it is the upper limit of the 95% confidence
interval, as determined by the method implemented in the BINOM programme66.
An interesting result from our association analyses is that we observed a P-value of
0.19 in Stage II pedigree data (affected subjects restricted to females) for the single
marker rs6137473. When we applied the TDT-HET method to the markers in the
candidate region for the same pedigrees, our multi-locus P-value became highly
significant. In addition, P-values obtained with female population data are also
highly significant for the same marker. We conjecture that this result is due to
differences in sample size, especially given that, for family-based association, trios
must contain at least one heterozygous parent to be informative. When we checked
the number of trios with female-only affected subjects for marker rs6137473,
we computed a total of 201 informative trios out of the total 600. We performed
comparative power calculations for case–control females, and for trios. We used
parameter settings from both Table 1 and Table 2. Using these values, we
computed a power value of 70% for the case–control design using the linear trend
test (weights equal to number of disease alleles in respective genotype) at a 10 5
significance level. On the other hand, we computed a power of 12% for the TDT
design at the same significance level. This decrease in power is substantial, and
provides one possible explanation as to why we did not observe a clear replication
with the TDT statistic at the single-locus level.
TSRHC III genotyping. We genotyped SNP rs6137473 in the 216 unrelated
cases and 336 unrelated controls using Taqman genotyping. Results were in
agreement with Hardy–Weinberg equilibrium (P40.05). We performed allelic
tests of association and CATT as implemented in the PLINK software32.
Candidate enhancer identification. Using the UCSC Genome Browser (https://
genome.ucsc.edu/cgi-bin/hgGateway), PhastCons (http://compgen.bscb.cornell.
edu/phast/help-pages/phastCons.txt) conserved elements and PhyloP (http://
compgen.bscb.cornell.edu/phast/help-pages/phyloP.txt) scores, we analysed
chr20:21,815,192–21,988,830 (hg19) for evolutionary conserved sequences. In
addition, we used enhancer mark data (H3K27ac and H3K4me1) from the
ENCODE project for human skeletal muscle myoblast cells and human embryonic
stem cells (H1-hESC), as well as DNase hypersensitivity data to identify putative
regulatory elements within the chromosome 20 region. These two methods of
analysis led to the selection of ten regions that were conserved between human and
other placental mammals or were predicted regulatory elements based on
ENCODE data.
Re-sequencing study. To identify individuals for re-sequencing we used the top
Stage I CATT-associated SNP markers on chromosome 20 (rs6137473, rs6106434,
r169311). Two of these SNPs (rs6106434 and rs169311) flank the Xe1 enhancer
region. We determined all possible genotype patterns of the three markers.
To prioritize cases and controls for re-sequencing, we selected the multi-locus
genotype pattern (MLGP) that (i) showed the largest difference in frequency
between cases and controls, (ii) had at least five samples in cases and controls and
(iii) for which the frequency in cases was greater than in controls. The MLGP that
met these criteria was GG/AA/AA, corresponding to the homozygous minor alleles
at rs6137473, rs6106434 and rs169311, respectively. Forty-eight NHW IS cases with
this MLGP were selected for re-sequencing. PCR primers were designed to flank
PEC7 and Xe1 regions. PCR fragments were sequenced using the Sanger method.
Zebrafish assays. Male and female strain AB zebrafish were used in all experi-
ments. Enhancer candidate sequences were cloned by PCR from human genomic
DNA (Roche) into the E1b-GFP-Tol2 enhancer assay vector containing an E1b
minimal promoter followed by GFP67 and verified by sequencing. For the PEC7
risk haplotype, PCR was carried out on an individual encompassing this haplotype
and sequence verified. Each construct was injected at two different days and Xe1,
PEC7-reference and PEC7 risk haplotype at four different days following standard
procedures68,69 into at least 100 zebrafish embryos along with Tol2 mRNA70 to
facilitate genomic integration. GFP expression was observed and annotated up to
48 h.p.f using a Leica M165 FC microscope. An enhancer was considered positive if
at least 10% of all fish surviving to 48 h.p.f. showed a consistent expression pattern
after subtracting out percentages of tissue expression in fish injected with the
empty enhancer vector. For each construct, at least 100 fishes were analysed for
GFP expression up to 48 h.p.f. All animal work was approved by the University of
California San Francisco Institutional Animal Care and Use Committee.
Pax1 immunohistochemistry. All animal work was approved by the University
of Texas Southwestern Medical Center Institutional Animal Care and Use
Committee. Male and female BL6 mice were euthanized at different developmental
stages (E13.5, E16, E18, P1, P14, P28, P84) by asphyxiation with CO2. Spines were
excised and fixed with 10% buffered formalin for 3 days and then processed
in a Leica ASP300S tissue processor and embedded in paraffin. Four-micrometre
sections were cut in series in the frontal plane and loaded onto 3-aminopropyl-
triethoxysilane-coated slides. Antigen retrieval was performed with 0.25% Trypsin
(Sigma-Aldrich) and endogenous peroxidase was blocked with 3% H2O2 (Thermo
Fisher Scientific Inc.). Slides were incubated with rabbit polyclonal antibody
(1:15,000, Sigma-Aldrich catalogue number SAB2101727) directed against a PAX1-
specific peptide and detected by goat anti-rabbit IgG-HRP (1:500, EMD Millipore
Corporation) and 3,30-diaminobenzidine (Dako) as chromogenic substrate. After
Pax1 staining, sections were counterstained with haematoxylin and Fast Green
(Sigma-Aldrich) and mounted with Cytoseal XYL (Thermo Fisher Scientific Inc.).
Haemotoxylin and eosin staining were also performed separately for pathological
characterization. Slides were viewed with an Olympus BX40 microscope.
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